Pharma Equity Group A/S

PEG.CO · CPH
Analyze with AI
6/30/2025
12/31/2024
9/30/2024
6/30/2024
Operating Activities
Net Income-DKK 5,041-DKK 7,147-DKK 5,861
Dep. & Amort.-DKK 138DKK 124DKK 124
Deferred TaxDKK 0DKK 0DKK 0
Stock-Based Comp.DKK 0DKK 0DKK 0
Change in WC-DKK 2,073DKK 1,122DKK 1,234
Other Non-CashDKK 593DKK 1,398DKK 632
Operating Cash Flow-DKK 6,659-DKK 4,503-DKK 3,871
Investing Activities
PP&E Inv.DKK 0DKK 0DKK 0
Net AcquisitionsDKK 0DKK 0DKK 0
Inv. PurchasesDKK 0DKK 0DKK 0
Inv. Sales/Matur.DKK 0DKK 0DKK 0
Other Inv. Act.DKK 0DKK 0DKK 0
Investing Cash FlowDKK 0DKK 0DKK 0
Financing Activities
Debt Repay.-DKK 39,918DKK 7,464DKK 3,694
Stock IssuedDKK 51,148DKK 0-DKK 1,105
Stock Repurch.DKK 0DKK 0DKK 0
Dividends PaidDKK 0DKK 0DKK 0
Other Fin. Act.-DKK 4,107-DKK 54-DKK 54
Financing Cash FlowDKK 7,123DKK 7,410DKK 2,535
Forex EffectDKK 0DKK 0DKK 0
Net Chg. in CashDKK 465DKK 2,907-DKK 1,336
Supplemental Information
Beg. CashDKK 3,769DKK 863DKK 2,199
End CashDKK 4,234DKK 3,770DKK 863
Free Cash Flow-DKK 6,659-DKK 4,503-DKK 3,871
Pharma Equity Group A/S (PEG.CO) Financial Statements & Key Stats | AlphaPilot